1. Takeshita, J., Grewal, S., Langan, SM et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377-390.doi:10.1016/j.jaad.2016.07.064 28212759
Google Scholar | Crossref | Medline2. Souza, CS., de Castro, CCS., Carneiro, FRO et al. Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: quality of life and prevalence. J Dermatol. 2019;46(1):3-10.doi:10.1111/1346-8138.14706 30474868
Google Scholar | Crossref | Medline3. Rapp, SR., Feldman, SR., Exum, ML., Fleischer, AB., Reboussin, DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401-407. [Jr].doi:10.1016/S0190-9622(99)70112-X 10459113
Google Scholar | Crossref | Medline | ISI4. Elmets, CA., Leonardi, CL., Davis, DMR et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073-1113.doi:10.1016/j.jaad.2018.11.058 30772097
Google Scholar | Crossref | Medline5. Strober, B., Gooderham, M., de Jong, EMGJ et al. Depressive symptoms, depression, and the effect of biologic therapy among patients in psoriasis longitudinal assessment and registry (PSOLAR). J Am Acad Dermatol. 2018;78(1):70-80.doi:10.1016/j.jaad.2017.08.051 29102053
Google Scholar | Crossref | Medline6. Mease, PJ., Gladman, DD., Papp, KA et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729-735.doi:10.1016/j.jaad.2013.07.023 23981683
Google Scholar | Crossref | Medline7. Gelfand, JM., Gladman, DD., Mease, PJ et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.doi:10.1016/j.jaad.2005.03.046 16198775
Google Scholar | Crossref | Medline8. Armstrong, AW., Schupp, C., Bebo, B. Psoriasis comorbidities: results from the National psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012;225(2):121-126.doi:10.1159/000342180 23108113
Google Scholar | Crossref | Medline9. Noe, MH., Shin, DB., Wan, MT., Gelfand, JM. Objective measures of psoriasis severity predict mortality: a prospective population-based cohort study. J Invest Dermatol. 2018;138(1):228-230.doi:10.1016/j.jid.2017.07.841 28843488
Google Scholar | Crossref | Medline10. Springate, DA., Parisi, R., Kontopantelis, E., Reeves, D., Griffiths, CEM., Ashcroft, DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176(3):650-658.doi:10.1111/bjd.15021 27579733
Google Scholar | Crossref | Medline | ISI11. Dhana, A., Yen, H., Yen, H., Cho, E. All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1332-1343.doi:10.1016/j.jaad.2018.12.037 30590074
Google Scholar | Crossref | Medline12. Semenov, YR., Herbosa, CM., Rogers, AT et al. Psoriasis and mortality in the United States: data from the National health and nutrition examination survey. J Am Acad Dermatol. 2021;85(2):396-403.doi:10.1016/j.jaad.2019.08.011 31415837
Google Scholar | Crossref | Medline13. Yeung, H., Takeshita, J., Mehta, NN et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173-1179.doi:10.1001/jamadermatol.2013.5015 23925466
Google Scholar | Crossref | Medline | ISI14. Langan, SM., Seminara, NM., Shin, DB et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132(3 Pt 1):556-562.doi:10.1038/jid.2011.365 22113483
Google Scholar | Crossref | Medline15. Svedbom, A., Dalén, J., Mamolo, C et al. Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study. Acta Derm Venereol. 2015;95(7):809-815.doi:10.2340/00015555-2095 25766866
Google Scholar | Medline16. Sampogna, F., Sera, F., Abeni, D. IDI multipurpose psoriasis research on vital experiences (IMPROVE) Investigators. measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol. 2004;122(3):602-607.
Google Scholar | Crossref | Medline17. Dowlatshahi, EA., Wakkee, M., Arends, LR., Nijsten, T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134(6):1542-1551.doi:10.1038/jid.2013.508 24284419
Google Scholar | Crossref | Medline | ISI18. Kimball, AB., Jacobson, C., Weiss, S., Vreeland, MG., Wu, Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-392.doi:10.2165/00128071-200506060-00005 16343026
Google Scholar | Crossref | Medline | ISI19. Daudén, E., Castañeda, S., Suárez, C et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27(11):1387-1404.doi:10.1111/jdv.12024 23134338
Google Scholar | Crossref | Medline20. Dominguez, PL., Assarpour, A., Kuo, H., Holt, EW., Tyler, S., Qureshi, AA. Development and pilot-testing of a psoriasis screening tool. Br J Dermatol. 2009;161(4):778-784.doi:10.1111/j.1365-2133.2009.09247.x 19566664
Google Scholar | Crossref | Medline21. Tom, BDM., Chandran, V., Farewell, VT., Rosen, CF., Gladman, DD. Validation of the Toronto psoriatic arthritis screen version 2 (TOPAS 2). J Rheumatol. 2015;42(5):841-846.doi:10.3899/jrheum.140857 25834198
Google Scholar | Crossref | Medline